Management of cardiogenic shock complicating acute myocardial infarction

Cardiogenic shock complicates approximately 5–10% of cases with acute myocardial infarction and carries a poor prognosis. Early revascularization remains the cornerstone treatment of cardiogenic shock complicating myocardial infarction. Inotropic and/or vasopressor agents can be used for haemodynami...

Full description

Saved in:
Bibliographic Details
Published inEuropean Heart Journal: Acute Cardiovascular Care Vol. 4; no. 3; pp. 278 - 297
Main Authors Van Herck, Jozef L, Claeys, Marc J, De Paep, Rudi, Van Herck, Paul L, Vrints, Christiaan J, Jorens, Philippe G
Format Book Review Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cardiogenic shock complicates approximately 5–10% of cases with acute myocardial infarction and carries a poor prognosis. Early revascularization remains the cornerstone treatment of cardiogenic shock complicating myocardial infarction. Inotropic and/or vasopressor agents can be used for haemodynamic stabilization, although this comes at the expense of increased myocardial oxygen consumption and extended myocardial ischaemia. In recent years, the use of mechanical circulatory support has significantly increased. However, there is only limited data available from randomized trials evaluating the different percutaneous support systems. This review summarizes the available literature concerning the management of cardiogenic shock and gives an overview of the recommendations of the European and German–Austrian guidelines on cardiogenic shock.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2048-8726
2048-8734
DOI:10.1177/2048872614568294